Samuel A. Hamood - Oct 1, 2021 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Role
Director
Signature
/s/ Sydney Gaylin, Attorney-in-Fact
Stock symbol
FNCH
Transactions as of
Oct 1, 2021
Transactions value $
$0
Form type
3
Date filed
10/5/2021, 07:49 PM
Previous filing
Sep 15, 2021
Next filing
May 26, 2022

No securities are beneficially owned.

Remarks:

No securities beneficially owned. Exhibit List - Exhibit 24 - Power of Attorney